Roche announces Venclexta/Venclyxto combination improved overall survival in people with previously untreated acute myeloid leukaemia

Phase III VIALE-A study showed Venclexta/Venclyxto plus azacitidine helped people with the most common type of aggressive leukaemia in adults live longer compared to azacitidine alone Data will be shared with global health authorities and presented at an upcoming medical meeting  Basel, 23 March 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that... Read more

Statement on Jury Verdict in Delaware Trial Against Oxford Nanopore Technologies

MENLO PARK, Calif., March 18, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not overall favorable for Pacific Biosciences, but mixed in terms of its findings.... Read more

European Commission approves Venclyxto plus Gazyvaro for adults with previously untreated chronic lymphocytic leukaemia

Combination regimen offers a new 12-month, fixed-duration, chemotherapy-free treatment option for adult patients with chronic lymphocytic leukaemia Results of the phase III CLL14 study add to the growing body of evidence supporting the potential of Venclyxto-based combinations across multiple lines Data showed that a fixed duration of treatment with Venclyxto plus Gazyvaro reduced the risk... Read more

Brooks Automation Announces Realignment of its Life Sciences Segment

CHELMSFORD, Mass., March 10, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS), announced today new leadership appointments and a realignment of its Life Sciences business organization to enhance capabilities and provide for optimal growth and efficiency. Over the past decade, Brooks has undergone a transformation from a pure semiconductor automation company to a company addressing two... Read more

New Multi-Instrument Calibrator Designed to Improve Accuracy and Save Time for Leak Detection and Repair Compliance

New Multi-Instrument Calibrator Designed to Improve Accuracy and Save Time for Leak Detection and Repair Compliance Thermo Scientific MIC-6 Multi-Instrument Calibrator Designed to Streamline U.S. EPA LDAR Compliance MINNEAPOLIS, March 9, 2020 /PRNewswire/ — For refineries and petrochemical plants, a new multi-instrument calibrator is designed to save time and improve accuracy of daily calibrations and... Read more

New Functional Structural Biology Capabilities Enabled by Bruker GHz-Class NMR Technology

First 1.2 GHz NMR System Delivered to CERM at the University of Florence, Italy BALTIMORE–(BUSINESS WIRE)– At the Experimental Nuclear Magnetic Resonance Conference 2020 (ENC), Bruker Corporation (Nasdaq: BRKR) announces the recent delivery of the world’s first Avance™ NEO1.2 GHz NMR system to the CERM at the University of Florence, Italy, and the first installation... Read more

PerkinElmer First Quarter 2020 Financial Performance Update

WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it expects first quarter 2020 revenue and earnings per share, both on a GAAP and non-GAAP basis, to be below the Company’s previously communicated guidance. Prahlad Singh, president and chief executive officer of PerkinElmer, stated,... Read more

Studying Viral Entry into Cells

Researchers combine confocal and atomic force microscopy to better understand this critical step of viral infections Viruses cannot reproduce on their own. They require the internal machinery of host cells for replication and propagation. One of the challenges that successful viruses have overcome is evolving complex, multi-step mechanisms to bind to host cell surfaces and... Read more

Thermo Fisher Scientific to Acquire QIAGEN N.V.

WALTHAM, Mass. and VENLO, The Netherlands – March 3, 2020 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of molecular diagnostics and sample preparation technologies, today announced that their boards of directors, as well as the managing... Read more